Max Robotics — Global Service Robot Directory + US Certification

About

David Sun is a leading clinical researcher in the surgical treatment of drug-resistant epilepsy, with a particular focus on minimally invasive techniques. His major contributions center on advancing laser interstitial thermal therapy (LITT) as a safe and effective alternative to traditional open surgery for patients with epileptogenic foci. Sun’s landmark work includes a prospective multicenter study reporting one-year outcomes following LITT, which demonstrated significant seizure reduction and improved quality of life—a study that has garnered 53 citations and helped establish the procedure’s clinical utility. More recently, his 2025 investigation into LITT for mesial temporal lobe epilepsy provides critical data on seizure outcomes and procedural safety, further refining patient selection and surgical protocols. With a growing citation impact, Sun’s research bridges the gap between innovative thermal ablation technology and real-world clinical practice, offering hope to patients with otherwise refractory epilepsy. His work is essential reading for neurosurgeons, epileptologists, and researchers seeking evidence-based advances in epilepsy surgery.